These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30841477)

  • 1. Lysine crotonylation is involved in hepatocellular carcinoma progression.
    Wan J; Liu H; Ming L
    Biomed Pharmacother; 2019 Mar; 111():976-982. PubMed ID: 30841477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultradeep Lysine Crotonylome Reveals the Crotonylation Enhancement on Both Histones and Nonhistone Proteins by SAHA Treatment.
    Wu Q; Li W; Wang C; Fan P; Cao L; Wu Z; Wang F
    J Proteome Res; 2017 Oct; 16(10):3664-3671. PubMed ID: 28882038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global crotonylome reveals hypoxia-mediated lamin A crotonylation regulated by HDAC6 in liver cancer.
    Zhang D; Tang J; Xu Y; Huang X; Wang Y; Jin X; Wu G; Liu P
    Cell Death Dis; 2022 Aug; 13(8):717. PubMed ID: 35977926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class I histone deacetylases are major histone decrotonylases: evidence for critical and broad function of histone crotonylation in transcription.
    Wei W; Liu X; Chen J; Gao S; Lu L; Zhang H; Ding G; Wang Z; Chen Z; Shi T; Li J; Yu J; Wong J
    Cell Res; 2017 Jul; 27(7):898-915. PubMed ID: 28497810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota derived short chain fatty acids promote histone crotonylation in the colon through histone deacetylases.
    Fellows R; Denizot J; Stellato C; Cuomo A; Jain P; Stoyanova E; Balázsi S; Hajnády Z; Liebert A; Kazakevych J; Blackburn H; Corrêa RO; Fachi JL; Sato FT; Ribeiro WR; Ferreira CM; Perée H; Spagnuolo M; Mattiuz R; Matolcsi C; Guedes J; Clark J; Veldhoen M; Bonaldi T; Vinolo MAR; Varga-Weisz P
    Nat Commun; 2018 Jan; 9(1):105. PubMed ID: 29317660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone lysine crotonylation during acute kidney injury in mice.
    Ruiz-Andres O; Sanchez-Niño MD; Cannata-Ortiz P; Ruiz-Ortega M; Egido J; Ortiz A; Sanz AB
    Dis Model Mech; 2016 Jun; 9(6):633-45. PubMed ID: 27125278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel SAHA analogues inhibit HDACs, induce apoptosis and modulate the expression of microRNAs in hepatocellular carcinoma.
    Srinivas C; Swathi V; Priyanka C; Anjana Devi T; Subba Reddy BV; Janaki Ramaiah M; Bhadra U; Bhadra MP
    Apoptosis; 2016 Nov; 21(11):1249-1264. PubMed ID: 27502208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC5 promotes cell proliferation in human hepatocellular carcinoma by up-regulating Six1 expression.
    Feng GW; Dong LD; Shang WJ; Pang XL; Li JF; Liu L; Wang Y
    Eur Rev Med Pharmacol Sci; 2014; 18(6):811-6. PubMed ID: 24706304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma.
    Lao Y; Cui X; Xu Z; Yan H; Zhang Z; Zhang Z; Geng L; Li B; Lu Y; Guan Q; Pu X; Zhao S; Zhu J; Qin X; Sun B
    J Hepatol; 2024 Nov; 81(5):847-861. PubMed ID: 38825017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmasking the pathological and therapeutic potential of histone deacetylases for liver cancer.
    Zhao J; Gray SG; Greene CM; Lawless MW
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):247-256. PubMed ID: 30791763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
    Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
    Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Analysis of Lysine 2-Hydroxyisobutyrylome upon SAHA Treatment and Its Relationship with Acetylation and Crotonylation.
    Wu Q; Ke L; Wang C; Fan P; Wu Z; Xu X
    J Proteome Res; 2018 Sep; 17(9):3176-3183. PubMed ID: 30109935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA.
    Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L
    Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
    Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
    Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. O-GlcNAcylation of histone deacetylases 1 in hepatocellular carcinoma promotes cancer progression.
    Zhu G; Tao T; Zhang D; Liu X; Qiu H; Han L; Xu Z; Xiao Y; Cheng C; Shen A
    Glycobiology; 2016 Aug; 26(8):820-833. PubMed ID: 27060025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-663a inhibits hepatocellular carcinoma cell proliferation and invasion by targeting HMGA2.
    Huang W; Li J; Guo X; Zhao Y; Yuan X
    Biomed Pharmacother; 2016 Jul; 81():431-438. PubMed ID: 27261623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
    Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.